A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
|Podcasts|June 25, 2021
Helping families navigate a "post pandemic" world
Author(s)Miranda Hester
Contemporary Pediatrics spoke with Andrew J. Schuman, MD, FAAP, about how to help families with mixed COVID-19 vaccine status remain safe and healthy.
Advertisement
With COVID-19 vaccines available to everyone 12 years of age and older, life in the United States is starting to return to its familiar rhythms, but some families may be left wondering how to keep everyone in the family safe when only some can be vaccinated,
Contemporary Pediatrics spoke with Andrew J. Schuman, MD, FAAP, about how to help those families remain safe and healthy.
Advertisement
Related to this article
New real-world data reveal delays and disparities in nirsevimab administration, highlighting opportunities to improve timely RSV protection for infants.
CDC confirmed the first pediatric flu death of 2026-27, linked to H1N1, as early flu activity rises in 2026.
With California WNV activity at a 5-year high, CHLA outlines age-based repellent and bite-prevention guidance for children.
Missed the AAP's new congenital measles guidance? This easy-to-read FAQ covers what pediatric clinicians need to know.
Johanna Chang, MD, offers guidance on vaccination, infection prophylaxis, and clinical warning signs in children receiving biologic therapies.
A Contemporary Pediatrics Peer Exchange panel reviews RSV risk, testing, maternal vaccination, and long-acting monoclonal antibodies, and where infants still slip through the cracks.
A GBD analysis of 204 countries estimated measles cases in children under 5 rose from 11.1 million in 2019 to 15.6 million in 2023.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA investigates malignancy risk with SMA gene therapy Zolgensma
2
Maternal RSVpreF 78% effective against infant RSV hospitalization
3
Air pollution tied to higher pediatric atopic dermatitis burden
4
Skipping newborn vitamin K tied to 47% higher infant bleeding risk
5